In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Harbin Gloria Pharmaceuticals Co. Ltd.

www.gloria.cc

Latest From Harbin Gloria Pharmaceuticals Co. Ltd.

Wellness Industry News: Acting FDA Commissioner Named, Thorne Test Line Grows, Nitrosigine In Revel Energy, More

NCI's Sharpless named acting FDA head; Mannatech trims loss as costs grow; Nilo drinks to avoiding hangovers; Daoust leads Soylent Nutrition development, innovation; Viactiv in taller, narrower package; Revel Energy made with Nitrosigine; and Thorne has at-home tests for additional concerns.

Wellness Advertising, Marketing & Sales

GNC, Vitamin Shoppe Not On Same Page In Solving Similar Growth Challenges

Common thread between the manufacturers and retail chain operators offering their own and other brands extends to relatively recent executive suite shakeups following extended stretches of declining sales growth. GNC reported nearly $70m net income for 2018 after two years of net losses and Vitamin Shoppe trimmed its loss by more than $200m from 2017 to $12.1m.

Dietary Supplements Business Strategies

Health And Wellness Market News: GNC In China, Emme ABC Champ, USP Forum

GNC gets $150m investment from Harbin Pharmaceutical and launches e-commerce JV in China; Apple Rush adds NFL great Leonard Marshall to board; Children's bars from This Bar Saves Lives; USP hosts supplement stakeholder forum May 15; and more news.

Dietary Supplements Commercial

GNC Links Pipeline To Loyalty Program Trends, Builds Private Label Lines

CEO Ken Martindale says research and development linked to firm’s loyalty program, which provides data on the needs of the nearly 15m customers enrolled. “The data-driven insight we gain from our loyalty program are beginning to help us shape our product development and innovation,” he says.

China International
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Cardiovascular
  • Gastrointestinal
  • Infectious & Viral Diseases
  • Metabolic Disorders
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • China
  • Parent & Subsidiaries
  • Harbin Gloria Pharmaceuticals Co. Ltd.
  • Senior Management
  • Zhu Ji Man, Chmn.
  • Contact Info
  • Harbin Gloria Pharmaceuticals Co. Ltd.
    Phone: 451 57351368
    59 Beijing Rd.
    Harbin, 150025
    China
Advertisement
Advertisement
UsernamePublicRestriction

Register